Our EDMs

Market Information

4th March 2021

Thursday, March 04, 2021

PrimaryMarkets - Case Study

Significant Value Accretion via the PrimaryMarkets Global Trading Platform
 
 

VGW Holdings Ltd commenced trading on the PrimaryMarkets Platform in October 2018, with the first trade at A$0.16 per share.

VGW has since attracted widespread interest from PrimaryMarkets Investors and has seen significant increase in trading activity.

VGW has had a stellar 12 months, which has seen its share price rise from A$0.30 to currently A$2.35 per share (+572%).

If you wish to learn more about how PrimaryMarkets can help your business with liquidity please contact info@primarymarkets.com.


Company: Sydney Metro Fund
Sector: Managed Fund
Opportunity: The investment provides investors with regular income distributions, with a targeted return of RBA cash rate plus 6.25% pa.

Description: Sydney Metro Fund is a pooled mortgage fund that offers Australian wholesale and sophisticated investors the opportunity to gain exposure to a property portfolio of loans.

Sydney Metro Fund has substantial experience managing a wide variety of property assets including residential, commercial, industrial, as well as deep knowledge of the lending marketplace, having secured and placed hundreds of millions of dollars in debt financing.

For more information including an investment memorandum, click below.

 


 

Company: Agripower Australia Ltd
Sector: Agtech/Fertiliser producer
Update: Federal Minister Pitt announced the Federal Governments support for Agripower, Read More.

Agripower’s unique range of AgrisilicaTM fertilisers and soil amendments are produced in Queensland and sold both domestically and into Global export markets as an accredited organic agricultural input with applications across cropping, horticulture, orchards, lawns and turf.

Agripower is an Australian company. To buy or sell shares in Agripower click below.

 


 

Capital Raise - Pre-IPO - CLOSING SOON
Company: Inventive Healthcare Solutions Pty Limited (Inventive Health)
Sector: Health Technology/COVID-19 Testing

Opportunity: The Company has raised its targeted A$4.4M via the issue of convertibles notes. The notes have a conversion price equal to a 30% discount to the IPO price.

Inventive Health will, for a short period, accept over subscriptions.

Inventive Health has teamed up with Virusight, an Israeli medical diagnostic solutions company to deliver a world first point-of-care test that provides on-site analysis and results within seconds for a COVID-19 test thereby reducing future outbreaks.

For more information including investment memorandum and term sheet click below.

 

Go Back

 
Become a Follower